As the expression of KRT14 and CLDN3 showed high consistency in both scRNA‐seq and 3D organoids, exhibiting clinical value, we further verified their heterogenous expression using TCGA cervical and endocervical cancer (CESC) dataset (Figure8A) and clinical samples from our center (Figure 3G). Here, CLDN3 is linked to endocervical carcinoma.